フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Mereo BioPharma Group plc 05 June 2020 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the...
Mereo BioPharma Group PLC on Thursday said it has completed a USD70 million capital raise in a private placement with ...
Mereo BioPharma Group plc 04 June 2020 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this...
Mereo BioPharma Group plc 04 June 2020 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction...
Mereo BioPharma Group plc 04 June 2020 NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE...
Mereo BioPharma Group plc 03 June 2020 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this...
Mereo BioPharma Group plc 03 June 2020 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction...
Mereo BioPharma Group plc 27 May 2020 Notice of Annual General Meeting London and Redwood City, Calif., May 27, 2020 - Mereo BioPharma Group plc...
Mereo BioPharma Group plc 22 May 2020 Annual General Meeting London and Redwood City, Calif., May 22, 2020 - Mereo BioPharma Group plc (NASDAQ:...
Mereo BioPharma Group plc 21 May 2020 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the...
Mereo BioPharma Group PLC on Friday said it still expects trials of its Setrusumab osteogenesis imperfecta treatment ...
Mereo BioPharma Group plc 27 March 2020 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS DEFINED UNDER THE MARKET ABUSE REGULATION (EU) NO...
Mereo BioPharma Group plc 06 March 2020 Mereo BioPharma Group plc Block Listing Interim Review Pursuant to AIM Rule 29 and Schedule 6 of the AIM...
Mereo BioPharma Group PLC on Friday said it successfully completed a type B end-of-phase 2 meeting with the US Food & ...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約